Literature DB >> 6109987

Aspirin and senile cataracts in rheumatoid arthritis.

E Cotlier, Y R Sharma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6109987     DOI： 10.1016/s0140-6736(81)91965-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  13 in total

1.  Aspirin and cataract.

Authors:  H Cheng
Journal:  Br J Ophthalmol       Date:  1992-05       Impact factor: 4.638

2.  The absence of SIRT3 and SIRT5 promotes the acetylation of lens proteins and improves the chaperone activity of α-crystallin in mouse lenses.

Authors:  Sandip K Nandi; Rooban B Nahomi; Peter S Harris; Cole R Michel; Kristofer S Fritz; Ram H Nagaraj
Journal:  Exp Eye Res       Date:  2019-03-05       Impact factor: 3.467

Review 3.  Aspirin and the elderly. Current status.

Authors:  C Silagy
Journal:  Drugs Aging       Date:  1993 Jul-Aug       Impact factor: 3.923

Review 4.  Can drugs or micronutrients prevent cataract?

Authors:  J J Harding
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

5.  Effects of modifications of alpha-crystallin on its chaperone and other properties.

Authors:  Barry K Derham; John J Harding
Journal:  Biochem J       Date:  2002-06-15       Impact factor: 3.857

6.  Aspirin use and chronic diseases: a cohort study of the elderly.

Authors:  A Paganini-Hill; A Chao; R K Ross; B E Henderson
Journal:  BMJ       Date:  1989-11-18

7.  Glutathione adducts, not carbamylated lysines, are the major modification of lens alpha-crystallins from renal failure patients.

Authors:  J B Smith; G A Shun-Shin; Y Sun; L R Miesbauer; Z Yang; Z Yang; X Zhou; J Schwedler; D L Smith
Journal:  J Protein Chem       Date:  1995-04

8.  Does aspirin affect the rate of cataract formation? Cross-sectional results during a randomised double-blind placebo controlled trial to prevent serious vascular events. UK-TIA Study Group.

Authors: 
Journal:  Br J Ophthalmol       Date:  1992-05       Impact factor: 4.638

Review 9.  Aldose reductase inhibitors and cataract.

Authors:  M J Crabbe
Journal:  Int Ophthalmol       Date:  1991-01       Impact factor: 2.031

Review 10.  Pharmacological treatment strategies in age-related cataracts.

Authors:  J J Harding
Journal:  Drugs Aging       Date:  1992 Jul-Aug       Impact factor: 3.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.